Development of Droplet Digital PCR-Based Assays to Quantify HIV Proviral and Integrated DNA in Brain Tissues from Viremic Individuals with Encephalitis and Virally Suppressed Aviremic Individuals

• Published in: Microbiology spectrum Vol. 10; no. 1; p. e0085321
• Main Authors: Chung, Hye Kyung, Hattler, Julian B, Narola, Jigna, Babbar, Harita, Cai, Yanhui, Abdel-Mohsen, Mohamed, Kim, Woong-Ki
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 23.02.2022
• Subjects: antiretroviral therapy; brain; Brain - virology; Clinical Microbiology; DNA, Viral - genetics; droplet digital PCR; Encephalitis - immunology; Encephalitis - virology; HIV Infections - immunology; HIV Infections - virology; HIV-1; HIV-1 - genetics; HIV-1 - isolation & purification; HIV-1 - physiology; HIV-associated neurocognitive disorders; Humans; Polymerase Chain Reaction - methods; Proviruses - genetics; Proviruses - isolation & purification; Proviruses - physiology; Research Article; reservoir; Viral Load; Viremia - immunology; Viremia - virology; Virus Integration; HIV-1; reservoir; brain; droplet digital PCR; antiretroviral therapy; HIV-associated neurocognitive disorders
• ISSN: 2165-0497; 2165-0497
• DOI: 10.1128/spectrum.00853-21

Although combination antiretroviral therapy (cART) can suppress the replication of HIV, the virus persists and rebounds when treatment is stopped. To find a cure that can eradicate latent reservoir, a method should be able to quantify the lingering HIV. Unlike other digital PCR technologies, droplet digital PCR (ddPCR), provides absolute quantification of target DNA molecules using fluorescent dually labeled probes by massively partitioning the sample into droplets. ddPCR enables exquisitely sensitive detection and quantification of viral DNA from very limiting clinical samples, including brain tissues. We developed and optimized duplex ddPCR assays for the detection and quantification of HIV proviral DNA and integrated DNA in the brain of HIV-1-infected patients. We have applied these approaches to successfully analyze 77 human brain tissues obtained from 27 HIV-1-infected individuals, either fully virally suppressed or with encephalitis, and were able to quantify low levels of viral DNA. Further developments and advancement of digital PCR technology is promising to aid in accurate quantification and characterization of the persistent HIV reservoir. We developed ddPCR assays to quantitatively measure HIV DNA and used this ddPCR assays to detect and quantitatively measure HIV DNA in the archived brain tissues from HIV patients. The tissue viral loads assessed by ddPCR was highly correlative with those assessed by qPCR. HIV DNA in the brain was detected more frequently by ddPCR than by qPCR. ddPCR also showed higher sensitivity than qPCR since ddPCR detected HIV DNA signals in some tissues from virally suppressed individuals while qPCR could not.